Lectra
Jean Marie Canan (Source: Lectra)
Effective June 1, 2021, Jean Marie Canan became a member of Lectra’s Audit Committee, Compensation Committee and Strategic Committee. This appointment follows the agreement reached for the acquisition by Lectra (France) of Gerber Technology (USA), of which American Industrial Partners (AIP) was the sole shareholder.
The appointment of Jean Marie Canan as Director, after that of Céline Abecassis-Moedas on April 30, 2021 will notably strengthen Lectra’s Strategic Committee, at a time when Lectra will be developing new offers for Industry 4.0 and examining an increasing number of investment projects in innovative companies.
Canan is currently Lead Independent Director and Chairman of the Audit Committee of REV Group, an American company listed on the NYSE; Director and Chairman of the Audit Committee of Acasti Pharma, a Canadian company listed on the NASDAQ and Director of the Angkor Hospital for Children, a leading non-profit pediatric hospital in Cambodia.